Boston Common Asset Management, LLC

Position in AZN — Astrazeneca PLC

CIK 1409427 BOSTON, MA

Position in AZN

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$7,104,492

-$973,639 QoQ

Shares Held

37,467

-8.5% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.49%

of 13F equity value

Holder Rank

#344

of 1,459 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 93% Shared 0% None 7%

Healthcare · as of Jun 30, 2026

Boston Common Asset Management, LLC holds $89,641,200 across 6 Drug Manufacturers - General names. AZN ranks #5 (7.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	22,557	$27,055,544
2	MRK	Merck & Co., Inc.	198,228	$25,472,298
3	NVS	Novartis AG	91,740	$14,377,492
4	GILD	Gilead Sciences, Inc.	84,463	$10,671,055
5	AZN	Astrazeneca PLC This page	37,467	$7,104,492
6	AMGN	Amgen Inc	13,698	$4,960,319

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,104,492	37,467	-8.5%	Shares	Sole	2026-07-21
2026-03-31	$8,078,131	40,960	-50.9%	Shares	Sole	2026-05-07
2025-12-31	$7,669,168	83,424	-56.7%	Shares	Sole	2026-05-07
2025-09-30	$14,775,428	192,589	+5.6%	Shares	Sole	2025-10-30
2025-06-30	$12,748,557	182,435	-1.9%	Shares	Sole	2025-07-22
2025-03-31	$13,665,855	185,930	-14.2%	Shares	Sole	2025-04-03
2024-12-31	$14,203,098	216,775	-17.3%	Shares	Sole	2025-01-15
2024-09-30	$40,767	262,273	-9.2%	Shares	Sole	2024-10-09
2024-06-30	$45,107	288,790	-3.6%	Shares	Sole	2024-07-08
2024-03-31	$40,424	299,683	-0.4%	Shares	Sole	2024-04-11
2023-12-31	$40,575	301,010	-2.8%	Shares	Sole	2024-01-09
2023-09-30	$41,974	309,762	-1.1%	Shares	Sole	2023-10-11
2023-06-30	$44,880	313,065	+15.5%	Shares	Sole	2023-07-24
2023-03-31	$37,654	271,130	—	Shares	Sole	2023-05-17
No filing history on record for this holder in this stock.